Testicular dysfunctions in patients after cytostatic treatment of non-seminomatous testis tumours.
In recent two years 28 patients were treated by combined cytostatic therapy for non-seminomatous testis tumour. Eleven months on the average since finishing chemotherapy they underwent andrological examination aimed at the changes of testicular function. Influence of cytostatics--bleomycin, cisplatinum and vinblastine on spermiogenesis of patient, on contralateral testis unaffected by tumour and on potency (data on erection, orgasm, volume of ejaculate and coitus frequency) was observed. 20% of patients had diminished contralateral testis. Decrease of ejaculate volume was stated by 64% of patients. Spermiogenesis damage was established in all patients (86% of patients had azoospermia and 14% had difficult oligoasthenospermia). One of the possible solutions of this negative effect on male fertility is represented by cryopreservation of semen before introduction of chemotherapy.